US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 17:36:24 Source：Culture Chronicle news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
- Ricky Stenhouse punching Kyle Busch could lead to suspension
- Timberwolves force Game 7 by blowing out Nuggets 115
- It's not a rock, it's the Athens Rock Lobsters. New minor league team honors B
- Funeral set for Roger Fortson, the Black US Air Force member killed in his home by Florida deputy
- Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed
- Chinese premier congratulates Mishustin on reassuming office as Russian PM
- Pictured: Writer, poet and anti
- For the children of Gaza, war means no school — and no indication when formal learning might return
- Supreme Court declines to hear challenge to Maryland ban on rifles known as assault weapons
- The latest hot spot for illegal border crossings is San Diego. But routes change quickly
- 'Constantly learning' Imanaga off to impressive start with the Chicago Cubs
- 'ALL Brits are welcome!' Mayor of Magaluf's message to UK holidaymakers following 'tourism
- Venezuela's barred opposition candidate is now the fiery surrogate of her lesser
- Scientists discover a NEW weight loss shot that could burn twice as much fat as Ozempic
- Minnesota Uber and Lyft driver pay package beats deadline to win approval in Legislature
- Father screamed 'my boy is dead' after son, six, 'fell from kitchen window' of 15th floor flat
- Scientists discover a NEW weight loss shot that could burn twice as much fat as Ozempic
- Houston storms: At least 4 killed, power cut in 900,000 homes
- Red Lobster seeks bankruptcy protection after closing some restaurants
- Protests are planned in Serbia against a real estate project financed by Trump's son
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Culture Chronicle news portal sitemap